With the introduction of integrated problem-based learning (PBL) program in the medical curriculum, there is a need to create laboratory classes that suit students’ learning needs and the changes introduced to the curriculum. This paper outlines the development and implementation of four integrated laboratory classes (ILCs) at King Saud University College of Medicine. It also examines whether core concepts addressed in these classes were learned and retained and how the students perceived the ILCs.
Summary: Primary ciliary dyskinesia (PCD) is a genetic disorder, usually autosomal recessive, causing early respiratory disease and later subfertility. Whole exome sequencing may enable efficient analysis for locus heterogeneous disorders such as PCD. We whole‐exome‐sequenced one consanguineous Saudi Arabian with clinically diagnosed PCD and normal laterality, to attempt ab initio molecular diagnosis.We reviewed 13 known PCD genes and potentially autozygous regions (extended homozygosity) for homozygous exon deletions, non‐dbSNP codon, splice‐site base variants or small indels. Homozygous non‐dbSNP changes were also reviewed exome‐wide. One single molecular read representing RSPH9 p.Lys268del was observed, with no wild‐type reads, and a notable deficiency of mapped reads at this location. Among all observations, RSPH9 was the strongest candidate for causality. Searching unmapped reads revealed seven more mutant reads. Direct assay for p.Lys268del (MboII digest) confirmed homozygosity in the affected individual, then confirmed homozygosity in three siblings with bronchiectasis. Our finding in southwest Saudi Arabia indicates that p.Lys268del, previously observed in two Bedouin families (Israel, UAE), is geographically widespread in the Arabian Peninsula. Analogous with cystic fibrosis CFTR p.Phe508del, screening for RSPH9 p.Lys268del (which lacks sentinel dextrocardia) in those at risk would help in early diagnosis, tailored clinical management, genetic counselling and primary prevention.
Internet use by patients raises awareness about their conditions, while its use by physicians assists their ability to make evidence-based decisions. This study aimed at assessing the extent, sources and effects of Internet use by parents of asthmatic children in Riyadh, Saudi Arabia. A cross-sectional design to collect data from two pediatric pulmonology clinics (public, private) for asthma management in Riyadh, Saudi Arabia, during the period of January to May 2011. A specially designed tool was used to collect data from a random sample of 500 parents of asthmatic children. This tool included questions on demographic data (parents, child) and internet use (sources, frequency, purposes). Most children (77%) in our study sample were diagnosed with asthma before their third birthday, by a treating physician (78%). Among Internet user parents (n=400), 53% used it for 10 to < 30 minutes or < 10 minutes (22%). Reported reasons for internet use were reassurance, clarification, online consulting, and new management schemes. Reported limitations for Internet use for managing asthma included the nonavailability of Arabic information and highly technical information. Parents suggested the need for the availability of the following online services: consulting/chatting with treating physician, receiving updates on asthma, booking appointments, and being directed to specific websites on asthma. Multivariate analysis showed that the most important predictors for internet use were: "higher mother education" (OR=7.02), followed by "higher father education" (OR=3.04) and "non-health related mother occupation" (OR=2.6). The application of the findings of this study may assist clinicians in the patient-centered shared management of asthmatic children.
Montelukast is a highly selective leukotriene-receptor antagonist (LTRA). It is widely used in the treatment of bronchial asthma, primarily as an adjunct to corticosteroids. Reactive oxygen species (ROSs) play an important role in the pathogenesis of asthma and oxidative stress contributing to the initiation and worsening of inflammatory respiratory disorders, such as asthma. Antioxidant drugs may have a role in minimizing or preventing damage in asthmatic children. The aim of this study was to assess the antioxidant effect of montelukast on the production of free radicals in the whole blood and polymorphonuclear neutrophils (PMNs) in asthmatic children. A group of 48 (38 males and 10 females), apparently healthy asthmatic children were recruited with ages ranging between 6 and 14 years. In asthmatic children, base line (premedication) and post medication free radicals activity in the whole blood and polymorphonuclear neutrophils (PMNs) was determined by measuring chemiluminescence (CL) response through chemiluminescence luminometer. Free radical productions were significantly decreased in the whole blood, when stimulated with Phorbol Myristate Acetate (p < 0.04) and Opsonised Zymosan (p < 0.05). The free radicals were also significantly decreased in isolated polymorphonuclear neutrophils (PMNs) when stimulated with Opsonised Zymosan (p < 0.05) after the post medication treatment of montelukast in asthmatic children. Montelukast decreased the reactive oxygen species production, both in the whole blood as well as isolated PMNs in asthmatic children.
In 2009, pandemic H1N1 influenza A caused significant morbidity and mortality worldwide; however, available data on disease characteristics and outcome of hospitalized children is limited. A prospective cohort study of children who required hospitalization because of the influenza A (H1N1) infection at King Khalid University Hospital in Riyadh, Saudi Arabia, over 6 months (July–December, 2009). Data was collected using a predesigned form for all admitted pediatric cases (0–12 years) presenting with the influenza-like illness and who tested positive for the novel influenza (H1N1) using reverse transcriptase polymerase chain reaction assay. The clinical course and features associated with the severe disease among such children were described Out of 1103 children with the influenza-like illness, 375 (34%) were confirmed pediatric cases of influenza A (H1N1), of whom 50 (13.3%) required hospitalization. The median age was 3 years (range, 1 month–12 years). Fever was the most frequent symptom (94%) at admission, followed by cough (86%) and other symptoms including vomiting and diarrhea. The majority (70%) of children had at least one underlying medical condition, with bronchial asthma being the most common (40%). All cases were treated with oseltamivir. Five children (10%) were admitted to the ICU, 4 required mechanical ventilation, and 2 died (4%). The majority of children with 2009 H1N1 influenza A–associated hospitalization in this series had an uncomplicated course. Respiratory complications and ICU admissions were more frequent in those with underlying disease, especially asthma and neuromuscular diseases. Efforts need to be focused prior to each influenza season and special emphasis needs to be given to children by immunizing them with H1N1 influenza A vaccination to avoid severe disease and minimize complications.